The present invention relates to conjugates of therapeutically useful anthracyclines with carriers such as polyclonal and monoclonal antibodies, proteins or peptides of natural or synthetic origin methods for their preparation, pharmaceutical composition containing them and use thereof in treating certain mammalian tumors.